23rd week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200170967 | MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA AND PATHOGENIC YEAST | 2020-06-04 |
20200170968 | Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection | 2020-06-04 |
20200170969 | REDUCTION OF HYPERGLYCEMIA BY ADMINISTRATION OF DIMETHYLFORMAMIDE FOR TREATING HYPERGLYCEMIC CONDITIONS, INCLUDING DIABETES MELLITUS | 2020-06-04 |
20200170970 | CERAMIDE NANOLIPOSOMES, COMPOSITIONS AND METHODS OF USING FOR IMMUNOTHERAPY | 2020-06-04 |
20200170971 | DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE | 2020-06-04 |
20200170972 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170973 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170974 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170975 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170976 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170977 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170978 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170979 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2020-06-04 |
20200170980 | COMPOSITION FOR THE TREATMENT OF SUPERFICIAL LESIONS | 2020-06-04 |
20200170981 | NON-RACEMIC BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH THE R-ENANTIOMER AND METHODS OF USE | 2020-06-04 |
20200170982 | S-BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH S-ENANTIOMER | 2020-06-04 |
20200170983 | METHODS FOR THE TREATMENT OF BLADDER CANCER | 2020-06-04 |
20200170984 | COMBINATION THERAPY TO TREAT UREA CYCLE DISORDERS | 2020-06-04 |
20200170985 | TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS | 2020-06-04 |
20200170986 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT OF MEMORY | 2020-06-04 |
20200170987 | REDUCED FAT, SHELF STABLE LIQUID NUTRITIONAL COMPOSITION | 2020-06-04 |
20200170988 | COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF ONCOLOGIC TREATMENT INDUCED OROGASTROINTESTINAL MUCOSITIS | 2020-06-04 |
20200170989 | Method for Treating Skin Cancer | 2020-06-04 |
20200170990 | METHOD FOR TREATING SCHNITZLER'S SYNDROME | 2020-06-04 |
20200170991 | Low-Dose Doxepin Formulations And Methods Of Making And Using The Same | 2020-06-04 |
20200170992 | TREATMENT OF HYPERPLASTIC TISSUE GROWTHS INCLUDING BENIGN PROSTATIC HYPERPLASIA (BPH) BY DIRECT INJECTION OF AN ANTINEOPLASTIC AGENT | 2020-06-04 |
20200170993 | LIPOSOMAL PACLITAXEL FORMULATION FOR TREATING BLADDER CANCER | 2020-06-04 |
20200170994 | SUBLINGUAL CANNABINOID COMPOSITIONS | 2020-06-04 |
20200170995 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COGNITIVE DECLINE AND PRESERVATION OF NEURONAL FUNCTION | 2020-06-04 |
20200170996 | USE OF A COMPOSITION COMPRISING 7-HYDROXYMATAIRESINOL | 2020-06-04 |
20200170997 | NOVEL COMPOUNDS | 2020-06-04 |
20200170998 | UMBILICAL CORD BLOOD SERUM AND UMBILICAL CORD BLOOD PLASMA PREPARATION IN COMBINATION WITH A NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND FREEZE-DRYING THE COMPOSITION | 2020-06-04 |
20200170999 | APREMILAST SUSTAINED RELEASE PREPARATION | 2020-06-04 |
20200171000 | PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE | 2020-06-04 |
20200171001 | COMBINATION THERAPY WITH 2,3-DIHYDRO-ISOINDOLE-1-ONE COMPOUNDS AND METHODS FOR TREATING PATIENTS WITH VARIOUS MUTATIONS | 2020-06-04 |
20200171002 | PREPARATION OF AND FORMULATION COMPRISING A MEK INHIBITOR | 2020-06-04 |
20200171003 | WILD BIRD TREATMENT COMPOSITION AND METHODS | 2020-06-04 |
20200171004 | AFFINITY BASED DRUG RELEASE FORMULATIONS | 2020-06-04 |
20200171005 | Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker | 2020-06-04 |
20200171006 | OINTMENT CONTAINING AN OXAZOLE COMPOUND | 2020-06-04 |
20200171007 | Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists | 2020-06-04 |
20200171008 | AR+ BREAST CANCER TREATMENT METHODS | 2020-06-04 |
20200171009 | COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST | 2020-06-04 |
20200171010 | COMPOSITIONS AND METHODS FOR REDUCING MUSCLE CONTRACTION | 2020-06-04 |
20200171011 | ALTERING EXPRESSION LEVEL OF GLUTATHIONE S-TRANSFERASE GENES BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | 2020-06-04 |
20200171012 | METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS | 2020-06-04 |
20200171013 | USE OF CICLOPIROX AS A MODULATOR OF THE HEME GROUP BIOSYNTHESIS AND IN THE TREATMENT OF PORPHYRIAS AND OTHER DISEASES | 2020-06-04 |
20200171014 | OXYBUTYNIN-XANOMELINE TRANSDERMAL THERAPEUTIC SYSTEM COMBINATIONS | 2020-06-04 |
20200171015 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | 2020-06-04 |
20200171016 | MULTI-TARGETING AGENTS FOR ALZHEIMER'S DISEASE THERAPY | 2020-06-04 |
20200171017 | SALTS OF HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | 2020-06-04 |
20200171018 | DEPOT ADMINISTRATION OF ILOPERIDONE | 2020-06-04 |
20200171019 | COMPOSITION | 2020-06-04 |
20200171020 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS | 2020-06-04 |
20200171021 | Methods of Managing Conditioned Fear with Neurokinin Receptor Antagonists | 2020-06-04 |
20200171023 | SOLUTION FOR ORAL ADMINISTRATION | 2020-06-04 |
20200171024 | BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF FIBROTIC LUNG DISEASE | 2020-06-04 |
20200171025 | PHARMACEUTICAL COMPOSITION COMPRISING BREXPIPRAZOLE AND PROCESS FOR PREPARATION THEREOF | 2020-06-04 |
20200171026 | PROSTACYCLIN RECEPTOR AGONISTS FOR REDUCTION OF BODY FAT | 2020-06-04 |
20200171027 | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | 2020-06-04 |
20200171028 | METALLOENZYME INHIBITOR COMPOUNDS | 2020-06-04 |
20200171029 | BIHETEROARYL COMPOUNDS AND USES THEREOF | 2020-06-04 |
20200171030 | DUAL INHIBITORS OF ALK5 AND P38A MAP KINASE | 2020-06-04 |
20200171031 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING SAME | 2020-06-04 |
20200171032 | METHODS AND MEDICAL USES | 2020-06-04 |
20200171033 | COMBINATION COMPRISING PALBOCICLIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPH- ENYL]-8,9-DIHYDRO-7H-BENZO[7] ANNULENE-2-CARBOXYLIC ACID AND ITS USE FOR THE TREATMENT OF CANCER | 2020-06-04 |
20200171034 | Methods Of Treating Follicular Lymphoma | 2020-06-04 |
20200171035 | METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR | 2020-06-04 |
20200171036 | Compositions Containing Ibrutinib | 2020-06-04 |
20200171037 | THERAPEUTIC REGIMEN | 2020-06-04 |
20200171038 | Medical use of pharmaceutical combination or composition | 2020-06-04 |
20200171039 | COMBINATIONS AND USES AND TREATMENTS | 2020-06-04 |
20200171040 | TREATMENT OF NEURODEGENERATIVE DISEASES, CAUSATION OF MEMORY ENHANCEMENT, AND ASSAY FOR SCREENING COMPOUNDS FOR SUCH | 2020-06-04 |
20200171041 | METHODS AND THERAPEUTICS TO REGULATE HYDROGEN SULFIDE BIOAVAILABILITY | 2020-06-04 |
20200171042 | BRAIN-PENETRANT CHROMONE OXIME DERIVATIVE FOR THE THERAPY OF LEVODOPA-INDUCED DYSKINESIA | 2020-06-04 |
20200171043 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | 2020-06-04 |
20200171044 | TREPROSTINIL ADMINISTRATION BY INHALATION | 2020-06-04 |
20200171045 | Neuroquiescence - A Treatment for Neurological and Nervous System Bioelectrical Dysregulation Associated with Seizures of Epilepsy | 2020-06-04 |
20200171046 | DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM) | 2020-06-04 |
20200171047 | ESTRADIOL BENZOATE AS A STERILANT | 2020-06-04 |
20200171048 | PREVENTION OF BOAR TAINT AND AGGRESSION | 2020-06-04 |
20200171049 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | 2020-06-04 |
20200171050 | SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION | 2020-06-04 |
20200171051 | METHODS FOR TREATING RENAL INJURY BY THERAPEUTICALLY UPREGULATING P21 | 2020-06-04 |
20200171052 | COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF | 2020-06-04 |
20200171053 | COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE | 2020-06-04 |
20200171054 | FORMULATIONS COMPRISING ALDOSTERONE RECEPTOR ANTAGONISTS AND TREATMENTS USING SAME | 2020-06-04 |
20200171055 | CO-CRYSTALS OF TRAMADOL AND COXIBS | 2020-06-04 |
20200171056 | SULFONYLUREA COMPOUNDS IN THE TREATMENT OF DISEASE ASSOCIATED WITH UV-INDUCED DAMAGE | 2020-06-04 |
20200171057 | Methods for Accelerated Return of Skin Integrity and for the Treatment of Impetigo | 2020-06-04 |
20200171058 | Treatment of upper aerodigestive tract disorders and cough | 2020-06-04 |
20200171059 | MODULATING PHOSPHATASE ACTIVITY IN CARDIAC CELLS | 2020-06-04 |
20200171060 | FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES | 2020-06-04 |
20200171061 | Methods for Cancer Therapy | 2020-06-04 |
20200171062 | HUMAN MILK OLIGOSACCHARIDE FOR IMPROVING IMMUNE FITNESS | 2020-06-04 |
20200171063 | Use Of Cholesterol For Promoting Survival And Proliferation Of Primary Medulloblastoma Cells | 2020-06-04 |
20200171064 | COMPOSITIONS AND METHODS FOR REDUCING MAJOR THROMBOTIC EVENTS IN CANCER PATIENTS | 2020-06-04 |
20200171065 | METHOD FOR TREATING LIVER DISEASE WITH KINSENOSIDE | 2020-06-04 |
20200171066 | EYE DROP FOR TREATING DRY EYE | 2020-06-04 |
20200171067 | Cancer Treatment Based on Delivery of Oligoes via Gap Junctions from Human Mesenchymal Stem Cells (hMSC) | 2020-06-04 |